
Starts 10 February 2027
10 to 11 February 2027
ImmunoMark San Diego 2027 · ImmunoMark Summit San Diego 2027: Immuno-Oncology & Biomarker Summit
San Diego, United States · In person
Convolign Business Consulting
- 2days
- In personevent
- Bookingopen, as stated by immunomarksummit.com
- $499cheapest ticket, as stated by immunomarksummit.com
About this conference
Two-day immuno-oncology and biomarker summit in San Diego with Immuno-Oncology and Biomarkers & CDx tracks, 1:1 meetings and a Day 1 drinks reception for 300+ senior leaders.
Details
Dates
10 to 11 February 2027CPD credits
Not stated yetFees
$2,499 / delegate; $499 / delegateRegistration
Open
Accreditation
Accreditation
Not stated yetAccrediting body
Not stated yetCredit type
Not stated yetCountry of accreditation
Not stated yet
Venue
San Diego, USA, CA
San Diego, United States
Interactive map. With the map focused, use the arrow keys to move it and the plus and minus keys to zoom. The address and a link to Google Maps are written beside it.
Around San Diego
Places, weather and events near the venue load as you scroll.
Explore more
Similar
- Conferences in North America in 2027, 71 conferences
- Conferences in the United States in 2027, 66 conferences
- Conferences in North America in winter 2026–27, 28 conferences
- Conferences in the United States in winter 2026–27, 27 conferences
- Conferences in North America in February 2027, 12 conferences
- Oncology conferences in February 2027, 3 conferences
- Oncology conferences in North America, 3 conferences
Oncology
12 to 13 February 2027 · Bangkok, Thailand
18 to 20 February 2027 · Lisbon, Portugal
16 Jan 2027 · Beverly Hills, United States
29 to 30 January 2027 · Houston, United States
3 to 4 March 2027 · London, United Kingdom
19 to 20 March 2027 · Athens, Greece
Spotted something wrong?
Tell us which detail looks off and we will check it against the source. We read every report and reply to each one.
Do you run this event? Claim this listing to keep its details right. Claiming gives you editing rights and no mark of approval.